// App-Quantinova.ai

2241 : Autoantibodies and Damage in Patients with Idiopathic Inflammatory Myopathies: A Longitudinal Multicenter Study from the EuroMyositis International Network

Researchers

Presenter

  • Fabricio Espinosa-Ortega

Principal Investigators

  • Karin Lodin

  • Marie Holmqvist

  • Maryam Dastmalchi

  • Angela Ceribelli

  • Jiri Venkovsky

  • Hector Chinoy

  • Louise Diederichsen

  • Samuel Shinjo

  • Ingrid Lundberg

  • Helene Alexanderson

Medical Centers

  • Karolinska Institutet, Stockholm, Sweden

  • Karolinska University Hospital Hudingge, Huddinge, Sweden

  • Karolinska University Hospital, Stockholm, Sweden

  • Humanitas Research Hospital, Humanitas University, Rozzano (MI) Italy, Borgo San Giacomo, Italy

  • Charles Univ Prague, Inst Rheumatol, Prague, Czech Republic, Prague, Czech Republic

  • The University of Manchester, Salford, United Kingdom

  • Copenhagen University Hospital, Rigshospitalet, Dragør, Denmark

  • ICESP Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil

  • Rheumatology Unit, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden

Locations

  • Sweden

  • Italy

  • Czech Republic

  • United Kingdom

  • Denmark

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Musculoskeletal

Disease

  • Idiopathic inflammatory myopathies

  • Myositis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Multicenteric

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved